BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32792953)

  • 1. Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography.
    Ruscitti F; Ravanetti F; Bertani V; Ragionieri L; Mecozzi L; Sverzellati N; Silva M; Ruffini L; Menozzi V; Civelli M; Villetti G; Stellari FF
    Front Pharmacol; 2020; 11():1117. PubMed ID: 32792953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
    Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
    BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivotal role of micro-CT technology in setting up an optimized lung fibrosis mouse model for drug screening.
    Khalajzeyqami Z; Grandi A; Ferrini E; Ravanetti F; Leo L; Mambrini M; Giardino L; Villetti G; Stellari FF
    PLoS One; 2022; 17(6):e0270005. PubMed ID: 35704641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema.
    Grandi A; Ferrini E; Mecozzi L; Ciccimarra R; Zoboli M; Leo L; Khalajzeyqami Z; Kleinjan A; Löwik CWGM; Donofrio G; Villetti G; Stellari FF
    Am J Physiol Lung Cell Mol Physiol; 2023 Feb; 324(2):L211-L227. PubMed ID: 36625471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
    Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
    Am J Physiol Lung Cell Mol Physiol; 2024 Apr; ():. PubMed ID: 38651940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin.
    Yang X; Huang XJ; Chen Z; Xu AL; Zhou H; Bi XL; Yan PY; Xie Y
    Heliyon; 2023 Mar; 9(3):e13598. PubMed ID: 36895392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in Mice.
    Barbayianni I; Ninou I; Tzouvelekis A; Aidinis V
    Front Med (Lausanne); 2018; 5():269. PubMed ID: 30320115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
    Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
    Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton's jelly.
    Chu KA; Yeh CC; Kuo FH; Lin WR; Hsu CW; Chen TH; Fu YS
    Stem Cell Res Ther; 2020 Nov; 11(1):513. PubMed ID: 33256831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
    Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis.
    Murgo A; Bignami F; Federico G; Villetti G; Civelli M; Sala A; Miglietta D
    Front Pharmacol; 2023; 14():1303646. PubMed ID: 38099140
    [No Abstract]   [Full Text] [Related]  

  • 13. Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis.
    Chen WC; Chen NJ; Chen HP; Yu WK; Su VY; Chen H; Wu HH; Yang KY
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
    Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
    Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose administration of bleomycin leads to early alterations in lung mechanics.
    Headley L; Bi W; Wilson C; Collum SD; Chavez M; Darwiche T; Mertens TCJ; Hernandez AM; Siddiqui SR; Rosenbaum S; Johnston RA; Karmouty-Quintana H
    Exp Physiol; 2018 Dec; 103(12):1692-1703. PubMed ID: 30260066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nintedanib on the microvascular architecture in a lung fibrosis model.
    Ackermann M; Kim YO; Wagner WL; Schuppan D; Valenzuela CD; Mentzer SJ; Kreuz S; Stiller D; Wollin L; Konerding MA
    Angiogenesis; 2017 Aug; 20(3):359-372. PubMed ID: 28283856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice.
    Bale S; Sunkoju M; Reddy SS; Swamy V; Godugu C
    Indian J Pharmacol; 2016; 48(6):643-648. PubMed ID: 28066100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
    Gilhodes JC; Julé Y; Kreuz S; Stierstorfer B; Stiller D; Wollin L
    PLoS One; 2017; 12(1):e0170561. PubMed ID: 28107543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes.
    Bonatti M; Pitozzi V; Caruso P; Pontis S; Pittelli MG; Frati C; Mangiaracina C; Lagrasta CAM; Quaini F; Cantarella S; Ottonello S; Villetti G; Civelli M; Montanini B; Trevisani M
    BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37730279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.